GainersToday.com
GainersToday.com, Tracking Stock Market Picks
Enter Symbol:
 
Natus Medical Incorporated (BABY) [hlAlert]

Rating:
Outperform
BABY
up 327.16 %

Natus Medical Incorporated (BABY) upgraded to Outperform by William Blair

Posted on: Friday,  May 1, 2009  9:25 AM ET by William Blair

William Blair rated Outperform Natus Medical Incorporated (NASDAQ: BABY) on 05/01/2009, when the stock price was $9.68. Since
then, Natus Medical Incorporated has gained 327.17% as of 01/12/2016's recent price of $41.35.
If you would have followed this William Blair's recommendation on BABY, you would have gained 327.16% of your investment in 2447 days.

Natus Medical Incorporated is a leading provider of healthcare products used for the screening, detection, treatment, monitoring and tracking of common medical ailments such as hearing impairment, neurological dysfunction, epilepsy, sleep disorders, and newborn care. Product offerings include computerized neurodiagnostic systems for audiology, neurology, polysomnography, and neonatology, as well as newborn care products such as hearing screening systems, phototherapy devices for the treatment of newborn jaundice, head-cooling products for the treatment of brain injury in newborns, and software systems for managing and tracking disorders and diseases for public health laboratories.

The Equity Research department provides the firm's clients with in-depth investment analysis and investment recommendations. Acting as the company's laboratory for new investment ideas, it specializes in providing investment analysis on quality growth companies. Located together in our Chicago office, our equity analysts currently follow a universe of nearly 360 companies.
Stock Market Advice
Date/Time (ET)SymbolRatingTermPrice (*)Target
5/1/2009 9:25 AM Buy
None
9.68
as of 12/31/2009
1 Week up  2.39 %
1 Month up  15.76 %
3 Months down  -0.06 %
1 YTD up  59.29 %
Previous Recommendations
Date/Time (ET)SymbolRatingTermPrice (*)Target
12/19/2008 8:25 AM Hold
None
13.37

(*) Stock Price at the time of the recommendation.
RSS Feed | |  Facebook |  Twitter |  Google Plus
Home | Terms of Use | Advertise | FAQ | Support Page | Contact Us | About Us | Privacy Policy